0001104659-18-002870.txt : 20180118 0001104659-18-002870.hdr.sgml : 20180118 20180118163625 ACCESSION NUMBER: 0001104659-18-002870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180116 FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BADDOUR LINDA CENTRAL INDEX KEY: 0001181151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36732 FILM NUMBER: 18534336 MAIL ADDRESS: STREET 1: PRA INTERNATIONAL STREET 2: 12120 SUNSET HILLS ROAD, SUITE 600 CITY: RESTON STATE: VA ZIP: 20190 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRA Health Sciences, Inc. CENTRAL INDEX KEY: 0001613859 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 463640387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 9197868200 MAIL ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 4 1 a4.xml 4 X0306 4 2018-01-16 0 0001613859 PRA Health Sciences, Inc. PRAH 0001181151 BADDOUR LINDA C/O PRA HEALTH SCIENCES, INC. 4130 PARKLAKE AVENUE, SUITE 400 RALEIGH NC 27612 0 1 0 0 Executive VP & CFO Common Stock 2018-01-16 4 M 0 67000 11.73 A 67000 D Common Stock 2018-01-16 4 S 0 64405 90.26 D 2595 D Common Stock 2018-01-16 4 S 0 2595 90.56 D 0 D Stock Option (Right to Buy) 11.73 2018-01-16 4 M 0 39374 0 D 2023-12-20 Common Stock 39374 39931 D Stock Option (Right to Buy) 11.73 2018-01-16 4 M 0 27626 0 D 2023-12-20 Common Stock 27626 117669 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $89.54 to $90.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.54 to $90.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The options vested on September 23, 2017. The options vested on March 2, 2016 upon satisfaction of certain performance criteria. By: /s/ Timothy J. McClain, by power of attorney 2018-01-18